Cypress Bioscience, Inc.


 
Corporate Governance
Investor FAQs
Investor Relations
     Stock Information
     News
     Fundamentals
     Analyst Coverage
     Earnings Estimates
     Dividends and Splits
     SEC Filings
     Request Information
 
 

Investor Relations | News

DateTitle  
03/08/10Cypress Bioscience, Inc. to Present at Cowen and Company 30th Annual Health Care ConferencePrinter Friendly Version
02/26/10Cypress Bioscience, Inc. to Participate in RBC Capital Markets Healthcare ConferencePrinter Friendly Version
02/05/10Cypress Bioscience, Inc. to Participate in BIO CEO & Investor ConferencePrinter Friendly Version
11/30/09Cypress Bioscience, Inc. to Present at the Piper Jaffray 21st Annual Health Care ConferencePrinter Friendly Version
11/09/09Cypress Bioscience Announces Third Quarter 2009 Financial ResultsPrinter Friendly Version
10/30/09Cypress Bioscience, Inc. to Present at Oppenheimer 20th Annual Healthcare ConferencePrinter Friendly Version
10/17/09Forest Laboratories and Cypress Bioscience Announce Study Shows Patients Treated with Savella Experience Improvements in Pain and Physical FunctionPrinter Friendly Version
09/21/09Cypress Bioscience, Inc. to Present at UBS Global Life Sciences ConferencePrinter Friendly Version
09/08/09Cypress Bioscience, Inc. to Present at Baird's 2009 Health Care ConferencePrinter Friendly Version
08/10/09Cypress Bioscience Announces Second Quarter 2009 Financial ResultsPrinter Friendly Version
06/16/09 Cypress Bioscience, Inc. to Present at Jefferies 3rd Annual Healthcare ConferencePrinter Friendly Version
05/11/09Cypress Bioscience, Inc. Announces First Quarter 2009 Financial ResultsPrinter Friendly Version
05/11/09Cypress bioscience, inc. Ceo jay kranzler named Ernst & Young
Entrepreneur of the year ® finalist in San Diego
Printer Friendly Version
04/20/09Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)Printer Friendly Version
 

© 2005-2009 Cypress Bioscience, Inc.

Privacy      Legal Disclaimer